Hsia Judith, Jablonski Kathleen A, Rice Madeline Murguia, Sabatine Marc S, Zabalgoitia Miguel, Maggioni Aldo, Cuddy Thomas E, Domanski Michael J, Geller Nancy L, Flaker Greg, Solomon Scott, Omland Torbjørn, Rouleau Jean L
Department of Medicine, George Washington University, Washington, DC, USA.
Am J Cardiol. 2008 Feb 15;101(4):457-61. doi: 10.1016/j.amjcard.2007.09.107.
Although sudden cardiac death (SCD) has been extensively studied in patients with coronary artery disease (CAD) and low ejection fraction, prediction of SCD among individuals with preserved left ventricular systolic function is less well understood. We randomized 8,290 patients with stable CAD with preserved left ventricular systolic function to trandolapril or placebo in a secondary coronary prevention trial, and we used Cox proportional hazards models to identify independent baseline predictors of SCD during 4.8 year follow-up (median). Using a risk scoring algorithm based on simple clinical characteristics, we were able to distinguish individuals at higher risk for SCD. Independent determinants of SCD included age (p <0.001), current angina pectoris (p = 0.002), ejection fraction >40% to <50% (as opposed to >50%) (p <0.001), and diuretic (p <0.001) and digitalis use (p <0.001). Negative predictors included having prior coronary revascularization (p = 0.01) and being female (p = 0.02) or Caucasian (p = 0.006). Trandolapril neither increased nor decreased SCD. Thus, among patients with stable CAD with preserved left ventricular systolic function receiving current standard-of-care including coronary revascularization, clinical characteristics can identify individuals at higher risk for SCD.
尽管在冠状动脉疾病(CAD)和低射血分数患者中对心脏性猝死(SCD)已进行了广泛研究,但对于左心室收缩功能保留的个体中SCD的预测了解较少。在一项二级冠状动脉预防试验中,我们将8290例左心室收缩功能保留的稳定CAD患者随机分为trandolapril组或安慰剂组,并使用Cox比例风险模型来确定在4.8年随访(中位数)期间SCD的独立基线预测因素。使用基于简单临床特征的风险评分算法,我们能够区分SCD风险较高的个体。SCD的独立决定因素包括年龄(p<0.001)、当前心绞痛(p = 0.002)、射血分数>40%至<50%(相对于>50%)(p<0.001),以及使用利尿剂(p<0.001)和洋地黄(p<0.001)。负性预测因素包括既往有冠状动脉血运重建(p = 0.01)以及女性(p = 0.02)或白种人(p = 0.006)。trandolapril既未增加也未降低SCD。因此,在接受包括冠状动脉血运重建在内的当前标准治疗的左心室收缩功能保留的稳定CAD患者中,临床特征可识别出SCD风险较高的个体。